Structure-activity relationship studies of a series of peptidomimetic ligands for α4β1 integrin on Jurkat T-leukemia cells

Biopolymers - Peptide Science Section

Volumn 84, Issue 6, 2006, Pages 595-604

  Liu, Ruiwu ^a   Peng, Li ^a   Han, Huijun ^a   Lam, Kit S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

4 1 integrin; Cell adhesion assay; Jurkat T leukemia cells; Peptidomimetic ligand; SAR study

Indexed keywords

ASSAYS; ENZYMES; MOLECULAR STRUCTURE; OPTIMIZATION; SYNTHESIS (CHEMICAL); TUMORS;

CELL ADHESION ASSAY; JURKAT T-LEUKEMIA CELLS; PEPTIDOMIMETIC LIGANDS; SAR STUDY;

CELLS;

PEPTIDE DERIVATIVE; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BINDING AFFINITY; CELL ADHESION; IC 50; LEUKEMIA CELL; LEUKEMIA CELL LINE; MEDICAL INFORMATION; PROTEIN DETERMINATION; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CELL ADHESION; HUMANS; INHIBITORY CONCENTRATION 50; INTEGRIN ALPHA4BETA1; JURKAT CELLS; LIGANDS; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33845573167     PISSN: 00063525     EISSN: 10970282     Source Type: Journal    
DOI: 10.1002/bip.20588     Document Type: Article

References (18)

1. Hemler, M. E. Annu Rev Immunol 1990, 8, 365-400.
2. Holzmann, B.; Gosslar, U.; Bittner, M. Curr Top Microbiol Immunol 1998, 231, 125-141.
3. Yusuf-Makagiansar, H.; Anderson, M. E.; Yakovleva, T. V.; Murray, J. S.; Siahaan, T. J. Med Res Rev 2002, 22, 146-167.
4. Jackson, D. Y. Curr Pharm Design 2002, 8, 1229-1253.
5. Singh, J.; Adams, S.; Carter, M. E.; Cuervo, H.; Lee, W.; Lobb, R. R.; Pepinsky, R. B.; Petter, R.; Scott, D. Curr Topics Med Chem 2004, 4, 1497-1507.
6. Vincent, A. M.; Cawley. J. C.; Burthem, J. Blood 1996, 87, 4780-4788.
7. Marco, R. A.; Diaz-Montero, C. M.; Wygant, J. N.; Kleinerman, E. S.; McIntyre, B. W. J Cell Biochem 2003, 88, 1038-1047.
8. de la Fuente, M. T.; Casanova, B.; Garcia-Gila, M.; Silva, A.; Garcia-Pardo, A. Leukemia 1999, 13, 266-274.
9. Damiano, J. S.; Dalton, W. S. Leuk Lymphoma 2000, 38, 71-81.
10. Matsunaga, T.; Takemoto, N.; Sato, T.; Takimoto, R.; Tanaka, I.; Fujimi, A.; Akiyama, T.; Kuroda, H.; Kawano, Y.; Kobune, M.; Kato, J.; Hirayama, Y.; Sakamaki, S.; Kohda, K.; Miyake, K.; Niitsu, Y. Nat Med 2003, 9, 1158-1165.
11. Olson, D. L.; Burkly, L. C.; Leone, D. R.; Dolinski, B. M.; Lobb, R. R. Mol Cancer Ther 2005, 4, 91-99.
12. Garmy-Susini, B.; Jin, H.; Zhu, Y.; Sung, R. J.; Hwang, R.; Varner, J. J Clin Invest 2005, 115, 1542-1551.
13. Park, S. I.; Renil, M.; Vikstrom, B.; Amro, N.; Song, L.; Xu, B.; Lam, K. S. Lett Pept Sci 2002, 8, 171-178.
14. Mikawa, M.; Wang, H.; Guo, L.; Liu, R.; Marik, J.; Takada, Y.; Lam, K. S.; Lau, D. Mol Cancer Ther 2004, 3, 1329-1334.
15. Lin, K.; Ateeq, H. S.; Hsiung, S. H.; Ching, L. T.; Zimmerman, C. N.; Castro, A.; Lee, W. C.; Hammond, C. E.; Kalkunte, S.; Chen, L. L.; Pepinsky, R. B.; Leone, D. R.; Sprague, A. G.; Abraham, W. M.; Gill, A.; Lobb, R. R.; Adams, S. P. J Med Chem 1999, 42, 920-934.
16. Atherton, E.; Sheppard, R. C. Solid Phase Peptide Synthesis: A Practical Approach; Oxford University Press: Oxford, 1989.
17. Marik, J.; Song, A.; Lam, K. S. Tetrahedron Lett 2003, 44, 4319-4320.
18. Peng, L.; Liu, R.; Marik, J.; Wang, X.; Takada, Y.; Lam, K. S. Nat Chem Biol 2006, 2, 381-389.